National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection Trial
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to assess the impact of minocycline and creatine on the progression
of Parkinson's disease, in order to determine whether it is reasonable to proceed with
further study of either of these agents.
Phase:
Phase 2
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)